Search research articles
Contact Us
Filters
Showing results (341-350 of 346) with videos related to
Page
of 35
Sort By:
You have reached the last page of results.
This site can display upto 346 results.
Gynecologic Oncology
|
June 10, 2018
Is carboplatin-based chemotherapy as effective as cisplatin-based chemotherapy in the treatment of advanced-stage dysgerminoma in children, adolescents and young adults?
Rachana Shah, Caihong Xia, Mark Krailo, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
October 10, 2008
Novel selective allosteric activator of the M1 muscarinic acetylcholine receptor regulates amyloid processing and produces antipsychotic-like activity in rats
Carrie K Jones, Ashley E Brady, Albert A Davis, et al.
Gynecologic Oncology
|
August 16, 2017
An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience
Kate E Oliver, William E Brady, Michael Birrer, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
November 13, 2009
A selective allosteric potentiator of the M1 muscarinic acetylcholine receptor increases activity of medial prefrontal cortical neurons and restores impairments in reversal learning
Jana K Shirey, Ashley E Brady, Paulianda J Jones, et al.
Lancet (London, England)
|
February 6, 2022
Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281/LOGS): an international, randomised, open-label, multicentre, phase 2/3 trial
David M Gershenson, Austin Miller, William E Brady, et al.
Plos One
|
January 24, 2014
Optimizing viable leukocyte sampling from the female genital tract for clinical trials: an international multi-site study
Lyle R McKinnon, Sean M Hughes, Stephen C De Rosa, et al.
Page
of 35
Search research articles
Search
Showing results (341-350 of 346) with videos related to
Sort By:
Page
of 35
You have reached the last page of results.
This site can display upto 346 results.
Gynecologic Oncology
|
June 10, 2018
Is carboplatin-based chemotherapy as effective as cisplatin-based chemotherapy in the treatment of advanced-stage dysgerminoma in children, adolescents and young adults?
Rachana Shah, Caihong Xia, Mark Krailo, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
October 10, 2008
Novel selective allosteric activator of the M1 muscarinic acetylcholine receptor regulates amyloid processing and produces antipsychotic-like activity in rats
Carrie K Jones, Ashley E Brady, Albert A Davis, et al.
Gynecologic Oncology
|
August 16, 2017
An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience
Kate E Oliver, William E Brady, Michael Birrer, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
November 13, 2009
A selective allosteric potentiator of the M1 muscarinic acetylcholine receptor increases activity of medial prefrontal cortical neurons and restores impairments in reversal learning
Jana K Shirey, Ashley E Brady, Paulianda J Jones, et al.
Lancet (London, England)
|
February 6, 2022
Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281/LOGS): an international, randomised, open-label, multicentre, phase 2/3 trial
David M Gershenson, Austin Miller, William E Brady, et al.
Plos One
|
January 24, 2014
Optimizing viable leukocyte sampling from the female genital tract for clinical trials: an international multi-site study
Lyle R McKinnon, Sean M Hughes, Stephen C De Rosa, et al.
Page
of 35